ARTICLE | Management Tracks
Athersys chair Gil Van Bokkelen steps down; plus Strongbridge, Medical Alley Association, Freeline, AlzeCure, Egetis, Arena and Prime Movers
February 17, 2021 1:51 AM UTC
Regenerative medicine company Athersys Inc. (NASDAQ:ATHX) said Chairman and CEO Gil Van Bokkelen has stepped down. While the company searches for a successor, President and COO William Lehmann will be interim CEO. Ismail Kola, a director, will become chairman.
Rare disease play Strongbridge Biopharma plc (NASDAQ:SBBP) promoted Richard Kollender from COO to president and CFO, effective March 3. Kollender succeeds Robert Lutz, who will join iBio Inc. (NYSE-A:IBIO) as chief financial & business officer...